With Biotech IPOs Booming, Here Are 2 To Watch
“Amid a relatively dry IPO year, biotech IPOs have boomed,” notes the author of today’s article, who proceeds to highlight what he believes are two…
“Amid a relatively dry IPO year, biotech IPOs have boomed,” notes the author of today’s article, who proceeds to highlight what he believes are two…
“The company I’m showing you today is essential to biotech stocks. It’s a ‘biotech-enabler,’” declares the author of today’s article in regards to a firm…
If the biotech highlighted in today’s article ends up getting its drug approved, it would be the first Alzheimer’s treatment that actually reduces the cognitive…
There’s a new ETF on the scene with a focus on small-cap biotech companies, offering investors exposure to junior disruptors in the biotech space. For…
“With coronavirus cases climbing in the U.S., this is likely going to be a clear focus for quite some time,” declares the author of today’s…
“The paralyzing viral outbreak that has swept the planet, costing trillions in output and gumming up the wheels of the global economy has also created…
“Investors have rewarded tech stocks richly during, and prior to the pandemic. Yet, there are gems that remain hidden within the sector,” advises the author…
If your phone or car uses a lithium-ion battery, the company highlighted in today’s article likely manufactured the lithium chemical used in that battery –…
In this unusual earnings season that is getting underway, the author of today’s article observes that “Any stocks unfortunate enough to hiccup…will be severely punished.…
The market strategist cited in today’s article believes that the current stock market situation will get “resolved to the upside” – and for risk-tolerant investors…